NCT01004601View on ClinicalTrials.gov

Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

docetaxel

patients at one university-affiliated hospital received low dose single docetaxel (30 mg/m2 on days 1 and 8 every 3 weeks)following failure of previous treatment stage IIIb/IV NSCLC.

DRUG

pemetrexed

patients at one university-affiliated hospital received pemetrexed (500 mg/m2 every 3 weeks) following failure of previous treatment stage IIIb/IV NSCLC.

Trial Locations (1)

10507

Chang Gung Memorial Hospital, Taipei

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT01004601 - Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer | Biotech Hunter | Biotech Hunter